Quotes 5-day view Delayed Xetra
10/20/2020
10/21/2020
10/22/2020
10/23/2020
10/26/2020
Date
67.06(c)
67(c)
67.24(c)
68.64(c)
68.7 Last
1 492 261
670 858
748 396
807 171
624 837 Volume
-5.52% -0.09% +0.36% +2.08% +0.09% Change
Sales 2020
21 505 M - -
Net income 2020
1 548 M - -
Net Debt 2020
14 305 M - -
P/E ratio 2020
15,4x
Yield 2020
1,74%
Sales 2021
22 512 M - -
Net income 2021
1 696 M - -
Net Debt 2021
13 444 M - -
P/E ratio 2021
14,1x
Yield 2021
1,84%
Capitalization
23 836 M 23 792 M -
EV / Sales 2020
1,77x
EV / Sales 2021
1,66x
Nbr of Employees
124 736
Free-Float
65,1%
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows:
- clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions;
- manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by...
Notations Surperformance© of Fresenius Medical Care AG & Co. KGaA
Trading Rating : Investor Rating :
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
Fresenius Medical says fourth-quarter operating profit up 3%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short Term Mid-Term Long Term Trends Bearish Bearish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
21
Average target price
99,78 $
Last Close Price
81,40 $
Spread / Highest target
41,0%
Spread / Average Target
22,6%
Spread / Lowest Target
-1,84%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
